[Fertility sparing treatment in women affected by cervical cancer larger than 2cm]

Bull Cancer. 2016 Feb;103(2):173-9. doi: 10.1016/j.bulcan.2015.11.005. Epub 2015 Dec 8.
[Article in French]

Abstract

Objective: We report our experience on fertility sparing treatment in young women affected by cervical cancer of more than 2cm.

Methods: Between July 2012 and February 2014, five patients presenting cervical tumors larger than 2cm (IB1>2cm) (23-35) and wishing to preserve fertility have been treated at our institution. Laparoscopic pelvic and para-aortic lymphadenectomy was performed for all patients. When lymph nodes were free of disease, patients had neoadjuvant chemotherapy followed by surgical conservative treatment.

Results: Four patients underwent a cisplatin based neoadjuvant chemotherapy before conservative surgery: radical trachelectomy or simple trachelectomy. One patient with nodal involvement underwent a 3cycle chemotherapy followed by concurrent radiochemotherapy. Hematologic toxicity grade 3 was observed in one patient leading to a change of chemotherapy. Two patients showed complete disappearance of tumor and two a partial response to neoadjuvant treatment. After a mean follow up of 20.5months (14-33), no relapse was observed. To date, no pregnancy was obtained.

Conclusion: Lymph node staging followed by neoadjuvant chemotherapy and radical trachelectomy seems to be a promising treatment scheme for patients with cervical tumors IB1>2cm pN0 seeking parenthood.

Keywords: Cancer du col; Cervical cancer; Chimiothérapie néoadjuvante; Fertility sparing treatment; Neoadjuvant chemotherapy; Préservation de la fertilité; Trachelectomy; Trachélectomie.

Publication types

  • English Abstract

MeSH terms

  • Adult
  • Chemoradiotherapy
  • Chemotherapy, Adjuvant / adverse effects
  • Female
  • Fertility Preservation*
  • Follow-Up Studies
  • Humans
  • Lymph Nodes / pathology
  • Lymphatic Metastasis
  • Neoadjuvant Therapy
  • Time Factors
  • Trachelectomy / methods
  • Tumor Burden*
  • Uterine Cervical Neoplasms / pathology*
  • Uterine Cervical Neoplasms / therapy*